Compare NEXT & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEXT | CERT |
|---|---|---|
| Founded | 2010 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Retail: Computer Software & Peripheral Equipment |
| Sector | Energy | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | N/A | 2020 |
| Metric | NEXT | CERT |
|---|---|---|
| Price | $5.21 | $8.96 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $9.00 | ★ $13.75 |
| AVG Volume (30 Days) | ★ 3.7M | 2.1M |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $415,551,000.00 |
| Revenue This Year | N/A | $10.82 |
| Revenue Next Year | N/A | $6.77 |
| P/E Ratio | ★ N/A | $128.03 |
| Revenue Growth | N/A | ★ 11.47 |
| 52 Week Low | $4.99 | $8.03 |
| 52 Week High | $12.12 | $15.69 |
| Indicator | NEXT | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 35.05 | 44.95 |
| Support Level | $4.99 | $8.42 |
| Resistance Level | $6.44 | $9.42 |
| Average True Range (ATR) | 0.30 | 0.39 |
| MACD | -0.09 | 0.06 |
| Stochastic Oscillator | 13.45 | 40.95 |
NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.